Abstract Self-reported type 2 diabetes mellitus (T2DM) is a risk factor for many cancers, suggesting its pathology relates to carcinogenesis. We conducted a case-cohort study to examine associations of hemoglobin A1c (HbA1c) and c-pept... Read More
Female Breast Cancer Research Articles
Overview
4286 Articles
Published in last 50 years
Articles published on Female Breast Cancer
Journals
Select journals
Duration
Select duration
4306 Search results
Recency
Prospective associations of hemoglobin A1c and c-peptide with risk of diabetes-related cancers in the Cancer Prevention Study-II Nutrition Cohort
- Cancer Research Communications
on Jun 24, 2022
Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan.
- Breast cancer (Tokyo, Japan)
on Jun 22, 2022
Male breast cancer (MBC) is rare; however, its incidence is increasing. There have been no large-scale reports on the clinicopathological characteristics of MBC in Japan. We investigated patients diagnosed with breast cancer in the Japanese National ... Read More
Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan
- Breast Cancer
on Jun 22, 2022
Abstract Background Male breast cancer (MBC) is rare; however, its incidence is increasing. There have been no large-scale reports on the clinicopathological characteristics of MBC in Japan. Meth... Read More
Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer
- Breast Cancer
on Jun 21, 2022
Abstract Background Human epidermal growth factor receptor 2 (HER2) low breast cancer was considered as a distinct subtype different from HER2-zero breast cancer. Our study aimed to investigate the prognostic values of cli... Read More
Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer.
- Breast cancer (Tokyo, Japan)
on Jun 21, 2022
Human epidermal growth factor receptor 2 (HER2) low breast cancer was considered as a distinct subtype different from HER2-zero breast cancer. Our study aimed to investigate the prognostic values of clinicopathological features and recurrence score (... Read More
Views of breast cancer survivors on work participation guidance by general practitioners: a qualitative study
- BMC Primary Care
- VOL. 23
on Jun 17, 2022
BackgroundBreast cancer survivors can be at high risk of having work-related problems. Previous studies suggest that GPs could discuss work participation with cancer patients and provide guidance.The aim this study is to explore the experiences and e... Read More
Abstract 5983: Gene profile analysis of breast cancer lung metastasis, liver metastasis, brain metastasis and primary tumor
- Cancer Research
- VOL. 82
on Jun 15, 2022
Abstract Background: The incidence of male breast cancer (MBC) is lower than female breast cancer (FBC), representing 1% of all breast cancer worldwide. The difference with FBC may affect the treatment strategy of MBC, but the necessar... Read More
Abstract CT518: First-in-human dose-escalation study of the phosphatidylinositol 3-kinase α-selective inhibitor HS-10352 in advanced breast cancer
- Cancer Research
- VOL. 82
on Jun 15, 2022
Abstract Background: PIK3CA mutation is particularly prevalent in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. HS-10352 is a highly potent and selective small molecule inhibi... Read More
Abstract 3630: Impact of socioeconomic status on the risk of contralateral breast cancer among Asian/Pacific Islander subgroups
- Cancer Research
- VOL. 82
on Jun 15, 2022
Abstract Introduction: Breast cancer survivors have an increased risk of contralateral breast cancer (CBC), among whom minority breast cancer patients are at increased risk of this adverse outcome. Studies evaluating CBC risk by race/e... Read More
Abstract 5867: Examination of race/ethnicity differences in patient reported outcomes (PROs) among elderly female breast cancer patients in the SEER-MHOS database
- Cancer Research
- VOL. 82
on Jun 15, 2022
Abstract We use regression models to examine baseline differences in physical and mental health PROs [Physical and Mental Component Summary T-scores (PCS/MCS: are linear transformations of the 0-100 possible range scoring for 8 SF-36/V... Read More
Abstract 5772: Differences in clinical actionability by comparing mutational landscape of young and old breast cancer patients
- Cancer Research
- VOL. 82
on Jun 15, 2022
Abstract Background: Early-onset breast cancer (BC) is associated with poor prognosis, which is also characterized by high recurrence risk, distant metastases and advanced stages at the time of diagnosis. While germline mutations in BR... Read More
Analysis of a Trend Reversal in US Lumpectomy Rates From 2005 Through 2017 Using 3 Nationwide Data Sets.
- JAMA surgery
on Jun 8, 2022
Rates of lumpectomy for breast cancer management in the United States previously declined in favor of more aggressive surgical options, such as mastectomy and contralateral prophylactic mastectomy (CPM). To evaluate longitudinal trends in the rates o... Read More
A Radiomics Model for Preoperative Predicting Sentinel Lymph Node Metastasis in Breast Cancer Based on Dynamic Contrast-Enhanced MRI
- Frontiers in oncology
- VOL. 12
on Jun 6, 2022
PurposeTo develop a radiomics model based on preoperative dynamic contrast-enhanced MRI (DCE-MRI) to identify sentinel lymph node (SLN) metastasis in breast cancer (BC) patients.Materials and MethodsThe MRI images and clinicopathological data of 142 ... Read More
Presentation, Diagnosis and Treatment Delays in Breast Cancer Care and Their Associations in Sri Lanka, a Low-resourced Country.
- Clinical oncology (Royal College of Radiologists (Great Britain))
on Jun 4, 2022
Delays in breast cancer care, one important attributable factor for breast cancer being diagnosed at advanced stages, are not systematically studied in many countries. This study assessed the magnitude and factors associated with delays in breast can... Read More
Early alterations in cortical morphology after neoadjuvant chemotherapy in breast cancer patients: A longitudinal magnetic resonance imaging study
- Human Brain Mapping
on Jun 4, 2022
There is growing evidence that chemotherapy may have a significant impact on the brains of breast cancer patients, causing changes in cortical morphology. However, early morphological alterations induced by chemotherapy in breast cancer patients are ... Read More
Patient-centered Outcomes in Breast Cancer: Description of EQ-5D-5L and EORTC-QLQ-BR23 Measurements in Real-world Data and Their Association With Survival.
- Clinical oncology (Royal College of Radiologists (Great Britain))
on Jun 3, 2022
In recent years, major improvements in breast cancer treatments have led to a significant increase in survival. Despite that, this population's quality of life (QoL) information is lacking, especially real-world data. This was a prospective, multicen... Read More
Retrospective analysis: 5509 cases of “totally implantable venous access port systems implantation (TIVAPS) depth” assisted by digital radiography
- Langenbeck's archives of surgery
on Jun 3, 2022
Modern oncological treatment in breast cancer patients requires the precise delivery of chemotherapy infusion into the central venous systems without toxicity. TIVAPS is the significant method of chemotherapy delivery although certain internal or ext... Read More
Ovarian reserve in premenopausal women with breast cancer.
- Breast (Edinburgh, Scotland)
- VOL. 64
on Jun 2, 2022
As a special reproductive hormone and ovarian reserve indicator, the role of anti-Müllerian hormone (AMH) in premenopausal women with breast cancer deserves further study. We conducted an in-depth analysis of the data from the EGOFACT study (NCT02518... Read More
Young adult cancer incidence trends in Taiwan and the U.S. from 2002 to 2016
- Cancer Epidemiology
- VOL. 78
on Jun 1, 2022
Previous studies have not examined young adult cancer incidence trends in Taiwan, or comprehensively compared these trends at two nations with different population genetics, environmental exposures, and health care. Therefore, we compared the inciden... Read More
Efficacy and safety of palbociclib in treatment of HR-positive advanced breast cancer patients: A single center real-world experience.
- Journal of Clinical Oncology
- VOL. 40
on Jun 1, 2022
e13035 Background: With an estimated 2.3 million new cases (11.7% of all cases), female breast cancer is the leading cause of cancer globally as of 2020. Metastatic or advanced breast cancer is an incurable disease with a 5-year overall survival ra... Read More